Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Aligning Medication With Long-Term Goals and Treatment Pathways Patients begin medical weight loss for different reasons
weight loss ~15% over 68 wks Dual GIP / GLP-1 Not included Tirzepatide GLP-1 from $349/mo, any dose Receptor GLP-1 + GIP Dosing Once weekly Format Self-injection Avg
This approval marked a significant advancement in obesity treatment, offering a new tool for individuals struggling with weight loss
Ely Lilly, a competitor of Novo Nordisk, sells their popular Zepbound weight loss medication directly from their own pharmacy and through some telehealth companies for people not using insurance for between $349 and $499 per month, depending on dosage
It reduces appetite, slows digestion, and supports more effective insulin use
US$ 26.87
US$ 24.71
US$ 22.07
